FILE PHOTO: The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on a screen during ...

Deep-pocketed investors have adopted a bearish approach towards Kenvue (NYSE:KVUE), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

Kenvue (KVUE) announced the appointment of two new independent directors, Sarah Hofstetter and Erica Mann to the company’s board of directors.

Canaccord raised the firm’s price target on Kenvue (KVUE) to $29 from $24 and keeps a Buy rating on the shares. The firm raised its price ...